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1. Introduction 
Azoospermia is defined as the complete absence of spermatozoa upon examination of the 
semen [including capillary tube centrifugation (CTC), strictly confirmed by the absence of 
spermatozoa issued in urine after ejaculation]. The presence of rare spermatozoa 
(<500.000/ml) in seminal fluid after centrifugation is called "cryptozoospermia". The 
complete absence of spermatozoa should be confirmed with repeat testing after a long time, 
because many external factors (e.g., febrile episodes and some therapies) may cause 
transient azoospermia. Azoospermia is present in approximately 1% of all men, and in 
approximately 15% of infertile men. Azoospermia may result from a lack of spermatozoa 
production in the testes (secretory or Non-Obstructive Azoospermia, NOA), or from an 
inability of produced spermatozoa  to reach the emitted semen (excretory or Obstructive 
Azoospermia, OA); however, in clinical practice both components are sometimes present in 
a single patient (mixed genesis azoospermia).The initial diagnosis of azoospermia is made 
when no spermatozoa can be detected on high-powered microscopic examination of 
centrifuged seminal fluid on at least two occasions. The World Health Organization (WHO) 
Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interactions 
recommends that the seminal fluid be centrifuged for 15 minutes, preferably at a 
centrifugation speed of ≥3000 × g. 
The evaluation of a patient with azoospermia is performed to determine the etiology of the 
patient’s condition. The numerous etiologies for azoospermia fall into three principal 
categories: pre-testicular, testicular, and post-testicular. 
1. pre-testicular azoospermia affects approximately 2% of men with azoospermia, and is 
due to a hypothalamic or pituitary abnormality diagnosed with hypogonadotropic 
hypogonadism;  
2. testicular failure or non-obstructive azoospermia is estimated to affect from 49% to 93% 
of azoospermic men. While the term testicular failure would seem to indicate a 
complete absence of spermatogenesis, men with testicular failure actually have either 
                                                                          






reduced spermatogenesis [hypospermatogenesis], maturation arrest at an early or late 
stage of spermatogenesis, or a complete failure of spermatogenesis (noted with Sertoli-
cell only syndrome);  
3. post-testicular obstruction or retrograde ejaculation are estimated to affect from 7% to 
51% of azoospermic men. In these cases, spermatogenesis is normal even though the 
semen lacks spermatozoa. 
Diagnosis 
The minimum initial evaluation of an azoospermic patient should include a complete 
medical history, physical examination, and hormone level measurements. Relevant history 
should investigate prior fertility; childhood illnesses such as orchitis or cryptorchidism; 
genital trauma or prior pelvic/inguinal surgery; infections; gonadotoxin exposure, such as 
prior radiation therapy/chemotherapy and current medical therapy; and a familial history 
of birth defects, mental retardation, reproductive failure, or cystic fibrosis. Physical 
examination includes: testis size and consistency; consistency of the epididymides; 
secondary sex characteristics; presence and consistency of the vasa deferentia; presence of a 
varicocele; and masses upon digital rectal examination. The initial hormonal evaluation 
should include measurement of serum testosterone (T) and follicle stimulating hormone 
(FSH) levels. 
History and initial investigations for men with azoospermia 
Cryptorchidism: the bilateral form is almost always associated with azoospermia and 
irreversible gonadal secretory dysfunction. The age at which surgical intervention is 
practiced and subsequent gonadal development may sometimes affect the prognosis. In 
addition, not infrequently, germinal malformations are also associated with atrophy of the 
epydidimus and sometimes with iatrogenic damage to the vas deferens. In unilateral 
cryptorchidism, azoospermia is less frequent; azoospermia in a patient with unilateral 
cryptorchidism is likely the result of concurrent secretory dysfunction (dysgenesis) or other 
pathology of the contralateral testis. 
Reduced volume of ejaculate: occurs progressively in the post-inflammatory obstruction of 
the ejaculatory ducts (ED), with a concomitant reduction of seminal fructose and lowering of 
pH. Ejaculate volume is normally reduced in cases of vas deferens agenesis or in the 
presence of large seminal cysts (Müllerian  or Wolffian). The same phenomenon is present in 
primary hypogonadism. Partial retrograde ejaculation is present in patients with systemic 
neuropathy (e.g., juvenile diabetes and multiple sclerosis), and is a possible outcome of 
endoscopic urological surgery for bladder neck sclerosis. 
Urological symptoms and signs: the clinician must always pay close attention to symptoms, 
even prior symptoms that may previously have had no apparent significance, such as 
episodes of hemospermia, burning urination, urinary frequency, and urethral 
catheterization after surgery. All of these symptoms should raise the suspicion that the 
proximal or distal seminal tract may be obstructed (Silber, 1981). The presence of 
hypospadias may be associated with urinary abnormalities, hypogonadism, cryptorchidism, 
and the presence of residues in the Müllerian duct of the prostate (utricular cysts). These 
cysts can be responsible for extrinsic compression of the ED. 
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Surgery: Inguinal hernioplasty interventions (often performed during infancy) may have 
damaged the tubes, and then create a condition of seminal tract obstruction. Resection of the 
funicular vessels may result in hypotrophy of the gonad. 
Family history: Clinicians should be attentive to the concomitant presence of infertility in 
the patient’s male relatives (as a result of chromosomal abnormalities, genetic conditions, 
tuberculosis, etc.). Scrotal traumas are often responsible for complete or incomplete 
epididymis obstruction, as well as trophic changes of the gonad. 
Prior chemotherapy and radiotherapy: Drug and radiation treatments for tumors usually 
cause irreversible damage to spermatogenesis. Even high-dose hormone therapy; antibiotic 
therapy with tetracyclines, nitrofurans, and sulfasalazine; or other drug therapies often 
temporarily alter spermatogenesis. 
Chronic obstructive pulmonary diseases are frequently associated with obstruction of the 
epididymis (11-21%). This condition is often the result of primary ciliary dyskinesia (also 
known as Kartagener Syndrome) or cystic fibrosis, the latter often characterized by agenesis 
of the distal epididymis, vas deferens, and seminal vesicles. The most common cause of 
congenital bilateral absence of the vas deferens (CBAVD) is a mutation of the cystic fibrosis 
trans-membrane conductance regulator (CFTR) gene. Almost all males with clinical cystic 
fibrosis have CBAVD, and approximately 70% of men with CBAVD and no clinical evidence 
of cystic fibrosis have an identifiable abnormality of the CFTR gene. 
The CFTR gene is extremely large and known mutations in the gene are extremely 
numerous. Clinical laboratories typically test for the 30–50 most common mutations found 
in patients with clinical cystic fibrosis. However, the mutations associated with CBAVD may 
be different. Because over 1,300 different mutations have been identified in this gene, this 
type of limited analysis is only informative if a mutation is found. A negative test result only 
indicates that the CBAVD patient does not have the most common mutations causing cystic 
fibrosis. Testing for abnormalities in the CFTR should include, at minimum, a panel of 
common point mutations and the 5T allele. There is currently no consensus on the minimum 
number of mutations that should be tested. 
Bilateral testicular atrophy may be caused by either primary or secondary testicular failure. 
Elevated serum FSH associated with either normal or low serum testosterone is consistent 
with primary testicular failure. All patients with these findings should be offered genetic 
testing for chromosomal abnormalities and Y-chromosome microdeletions. Low serum FSH 
associated with bilaterally small testes and low serum testosterone is consistent with 
hypogonadotropic hypogonadism (secondary testicular failure). These patients usually also 
have low serum luteinizing hormone (LH) levels. Hypogonadotropic hypogonadism can be 
caused by hypothalamic disorders (e.g., functioning and non-functioning pituitary tumors). 
Therefore, these patients should undergo further evaluation, including serum prolactin 
measurement and imaging of the pituitary gland. 
When the vasa deferentia and testes are palpably normal, semen volume and serum FSH are 
key factors in determining the etiology of azoospermia. Azoospermic patients with normal 
ejaculate volume may have reproductive system obstruction or spermatogenesis 
abnormalities. Azoospermic patients with low semen volume and normal-sized testes may 






Normal semen volume 
The serum FSH level of a patient with normal semen volume is a critical factor with which 
to establish whether a diagnostic testicular biopsy is needed to investigate spermatogenesis. 
Although a diagnostic testicular biopsy will determine whether spermatogenesis is 
impaired, it does not provide accurate prognostic information regarding whether or not 
sperm will be found on future sperm retrieval attempts for patients with NOA. Therefore, a 
testicular biopsy is not necessary to establish the diagnosis or to provide clinically useful 
prognostic information for patients with consistent clinical findings for the diagnosis of 
NOA (e.g., testicular atrophy or markedly elevated FSH). Conversely, patients who have a 
normal serum FSH should undergo a diagnostic testicular biopsy, because normal or 
borderline elevated serum FSH levels may suggest either obstruction or abnormal 
spermatogenesis. If the testicular biopsy is normal, an obstruction in the reproductive 
system must be found. Most men with OA, palpable vasa deferentia, and no history of 
iatrogenic vasal injury present with bilateral epididymal obstruction. Epididymal 
obstruction can be identified only by surgical exploration. Vasography may be utilized to 
determine whether there is an obstruction in the vas deferens or ED. 
Reduced semen volume 
Low ejaculate volume (< 1.0 ml) that is not caused by hypogonadism or CBAVD may be 
caused by ejaculatory dysfunction, but is most likely caused by EDO. Ejaculatory 
dysfunction rarely causes low ejaculate volume with azoospermia, although it is a well-
known cause of aspermia or low ejaculate volume with oligozoospermia. Additional 
seminal parameters that may be helpful in determining the presence of EDO are seminal pH 
and fructose, since the seminal vesicle secretions are alkaline and contain fructose. EDO is 
detected by transrectal ultrasonography (TRUS). The finding of midline cysts, dilated ED, 
and/or dilated seminal vesicles (>1.5 cm in antero-posterior diameter) on TRUS is 
suggestive, but not diagnostic, of EDO. Therefore, seminal vesicle aspiration (SVA) and 
seminal vesiculography may be performed under TRUS guidance to make a more definitive 
diagnosis of EDO. The presence of large numbers of sperm in the seminal vesicle of an 
azoospermic patient is highly suggestive of EDO. Seminal vesiculography performed 
contemporary with SVA can localize the site of obstruction. EDO is detected by TRUS, and 
is usually accompanied by dilation of the seminal vesicles (typically >1.5 cm). 
 
Fig. 1. Ultarsound Investigation: Intraprostatic cyst with ejaculatory duct obstruction 
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Genetic investigations for men with azoospermia 
All men with hypogonadotropic hypogonadism should be referred for genetics counseling, 
as almost all of the congenital abnormalities of the hypothalamus are due to a genetic 
alteration. 
If a genetic alteration is identified, then genetic counseling is suggested (Level of evidence 2, 
Grade B recommendation). In addition to mutations in the CFTR gene that give rise to 
CBAVD, genetic factors may play a role in NOA. The two most common categories of 
genetic factors are chromosomal abnormalities resulting in impaired testicular function, and 
Y-chromosome microdeletions leading to isolated spermatogenic impairment. 
Chromosomal abnormalities account for approximately 6% of all male infertility, and the 
prevalence increases with increased spermatogenic impairment (severe oligospermia and 
NOA). 
Approximately 13% of men with NOA or severe oligospermia may have an underlying Y-
chromosome microdeletion. Y chromosome microdeletions responsible for infertility — 
azoospermia factor (AZF) regions a, b, or c — are detected using sequence-tagged sites (STS) 
and polymerase chain reaction (PCR) analysis. Y chromosome microdeletions carry both 
prognostic significance for finding sperm, and consequences for offspring if these sperm are 
utilized. Although successful testicular sperm extraction has not been reported in infertile 
men with large deletions involving AZFa or AZFb regions, the total number of reports is 
limited. However, up to 80% of men with AZFc deletions may have retrievable sperm for 
intracytoplasmic sperm injection (ICSI). 
Treatments for azoospermia 
Obstructive azoospermia 
Instrumental and surgical treatments designed to restore natural fertility 
1. Microsurgical recanalization of the proximal seminal tract  
a. Obstruction of the epididymis: epididymal tubal vasostomy (vasoepididymostomy) 
b. Obstruction of the vas deferens: vasovasostomy 
2. Recanalization of the distal seminal tract 
a. Transurethral resection of the ejaculatory ducts (TURED) 
b. Transrectal ultrasound-guided by unblocking (TRUC) 
c. Seminal tract washout treatment 
3. Surgical or instrumental sperm collection for artificial reproductive treatment 
- Testis 
a. Testicular sperm extraction (TESE) 
b. Testicular sperm aspiration (TESA) 
c. Testicular fine needle aspiration (TEFNA) 
- Epididymis 
a. Microsurgical epididymal sperm aspiration (MESA) 
b. Percutaneous epididymal sperm aspiration (PESA) 
c. Epididymal sperm extraction (ESE) 
- Vas deferens and distal seminal tract 






b. Distal seminal tract aspiration (DISTA) 
c. Transrectal ultrasound-guided aspiration of sperm from intraprostatic cysts 
communicating with the ED 
d. Seminal tract washout designed to recover sperm for in vitro fertilization (IVF) 
Secretory azoospermia 
a. Medical treatment 
b. The varicocele in azoospermia 
c. Surgical removal of sperm from the testicle or instrument for artificial insemination 
1. Testicular sperm extraction (TESE) 
2. Testicular sperm aspiration (TESA) and Testicular fine needle aspiration (TEFNA) 
Retrograde ejaculation 
a. Pharmacotherapy 
b. Recovery of sperm from the urine as an aid to artificial insemination 
Anejaculation 
a. Etiologic treatments 
b. Treatment aimed to recover sperm for assisted reproductive technology (ART) 
1. Vibratory ED massage 
2. Electroejaculation 
3. Seminal tract washout designed to recover sperm for IVF or cryopreservation of 
testicular sperm 
Obstructive azoospermia 
The aim of treating obstructive azoospermia is to restore the patency of the seminal tract 
and spontaneous fertility. Treatment choice depends on the localization and characteristics 
of the obstructing lesion. When it is not possible to restore the patency of the seminal tract, 
the next step is to proceed to surgical sperm recovery (to be used fresh or after 
cryopreservation for ART). 
2. Microsurgery: Reconstruction of the proximal seminal tract 
The correct implementation and results of microsurgical reconstruction of the proximal 
seminal tract depend upon the use of special instruments (surgical microscope), non-
reactive suture materials, and the technical skill of the operator. The surgical microscope is 
essential to evaluate the quantity and quality of sperm during seminal fluid aspiration. This 
determination dictates the choice of reconstructive surgery. 
Surgery is indicated in the following cases: 
- Azoospermia confirmed by at least two recent seminal examinations 
- Preservation of spermatogenesis on at least one side 
- Absence of retrograde ejaculation 
- Absence of seminal tract infection 
The reconstruction of the seminal tract is still subject to its proximal distal patency, which is 
demonstrated in the phase immediately preceding reconstructive surgery through 
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cannulation of the deferent (butterfly needle 23-25 Gauge) and injection of at least 10 ml of 
saline solution. 
Epididymal obstructions: Vasoepididymostomy 
Vasoepididymostomy is performed to treat congenital, infectious, post-vasectomy or 
idiopathic obstruction of the epididymis. The rate of restoration of patency varies between 
60% and 87%, and spontaneous pregnancies vary between 10% and 43%.5-8 Accuracy  
of microsurgical technique affects the outcome of reconstructive procedures on  
the male reproductive system. The best results are achieved by surgeons with training  
and ongoing experience in microsurgery. To maximize successful outcomes, surgeons  
performing vasectomy reversal should be comfortable with anastomoses involving 
extremely small luminal diameters, and must be competent with both vasovasostomy  
and vasoepididymostomy, because the latter may be unexpectedly necessary in many 
cases. 
Before vasoepididymostomy, or when anastomosis is not feasible, sperm aspiration and 
cryopreservation should be performed for future use for ICSI, in case of failure of the 
anastomosis. In some cases, the reappearance of sperm in the seminal liquid happens more 
than one year after surgery. Stricture of the anastomosis has been observed after some time, 
at rates varying between 10% and 21%. The absence of sperm in the epididymal tubule or 
the presence of diffuse fibrosis of the organ are two negative prognostic factors that indicate 
the presence of a secretory testicular pathology. The presence of ultrasound abnormalities of 
the distal seminal tract have recently been reported as adverse prognostic factors for the 
success rates of recanalization. Vasoepididymostomy in patients with obstruction secondary 
to vasectomy is more advantageous in terms of costs compared with MESA with ICSI 
pregnancies. 
Technical notes 
The epididymis is opened where there is a clear tubular dilation due to the obstacle; 
however, the opening should be as caudal as possible. The liquid that issues from the 
epididymis is immediately examined to assess the presence and motility of sperm. If the 
determination is negative, a more proximal tubule will be opened. If the goal is to make 
an end-to-end  vasostomy, after transverse incision of the epididymis tunica vaginalis, the 
section of the seminal tubules containing sperm should be chosen to perform the 
anastomosis with the deferent to reduce the possibility of developing strictures in the 
future. A latero-terminal vasostomy appears to avoid this eventuality without additional 
effort. Under optical magnification of the field (40×) (the center of a window previously 
prepared in the tunica vaginalis of the epididymis), a loop is opened longitudinally and 
the tubulus is anastomosed to deferent with two stitches (8-0 Prolene). To prevent leakage 
of seminal fluid and the resulting formation of granulomas, the stitches should be as 
superficial as possible and at the end it is recommended that fibrin glue be placed on the 
anastomosis. 
Obstructions of the vas deferens: Vasovasostomy 
The obstruction of the vas deferens that results from vasectomy or, more rarely, from an 







Fig. 2. Vasoepididymostomy 
lesions of the distal vas deferens, usually resulting in bilateral herniorrhaphy, the stumps of 
the vas deferens are often poorly identified in the context of scar tissue. It is therefore 
necessary to resort to a wide mobilization of the stumps to perform both proximal and distal 
anastomosis. The outer diameter of the duct remains constant as a result of obstruction, 
while the inner testicular slope expands approximately 2-4 times. Distal stump sclerosis may 
progress to scarring. Factors that will influence the success of the anastomosis are: 
- The use of a surgical microscope 
- The quality of the tissues involved in the anastomosis 
- The presence and characteristics of the fluid that is released from the proximal stump of 
the ductus 
- Distal patency of the seminal vesicle 
- The duration of obstruction 
The recanalization rates extrapolated from the main series (a total of 2385 cases treated) vary 
between 86% and 93%, while the cumulative spontaneous pregnancy rates range between 
52% and 82%. The duration of the obstruction appreciably affect the success rate of 
vasovasostomy. When the interval between obstruction and recanalization is shorter than 3 
years, patency and spontaneous pregnancies are obtained, respectively, in 97% and 76% of 
cases, compared with 88% and 53% when the interval is between 3 and 8 years, and 71% and 
30% when the interval is between 9 and 14 years. Deferential distal obstructions are often 
incorrigible. In these cases, the aspiration of sperm from the proximal deferential stump 
may be used or, if there is a concomitant epididymal obstruction, MESA or TESE may be 
employed (see related chapters). 
Technical Notes 
Reconstruction of the deferent can be performed in "double layer" or "single layer". In two-
layer vasovasostomy, the mucous layer and inner muscle of the two stumps are sutured 
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with 6 sutures (preferably non-absorbable or slow resorption 9/0-10/0); then, the outer 
muscular and serosal layers are secured with 6 sutures 8/0-9/0, interspersed with the first. 
However, the sutures pass through the wall of the deferent at ≥6 points, possibly full-
thickness. 
 
Fig. 3. Vaso-vasostomia 
3. Recanalization of the distal seminal tract 
Transurethral resection of the ejaculatory ducts (TURED) 
Transurethral resection of the ejaculatory ducts (TURED) was proposed in 1973 by Farley 
and Barnes for the resolution of (EDO). Since then, several studies have documented its 
effectiveness. The term also includes the endoscopic resection of the ED obstructing 
prostatic cysts, even if improperly, because in this case the ED are not properly resected, but 
only the anterior wall of the cyst, making it widely communicate with the prostatic urethra. 
The indications for TURED are represented by a complete or incomplete congenital or 
acquired obstruction of the distal seminal tract, caused by atresia, strictures, or scarring; or 
in the presence of gallstones of ED; or subsequent prostatic cysts, whether or not they 
communicate with the seminal tract. Only issues relating to the use of TURED in cases of 
azoospermia will be taken into account. 
Until a few years ago, TURED was the only therapeutic option in cases of obstruction of ED. 
Recently, successful sperm retrieval techniques for assisted reproduction (e.g., ICSI) and the 
introduction of new techniques (ultrasound-guided sclerotherapy of prostatic cysts, Seminal 
Tract Wash-out) have reduced its use. Nevertheless, TURED must still be considered an 
effective therapeutic method that allows patients to obtain natural pregnancies in a 
significant percentage of cases of obstructive azoospermia. A recent review of 164 cases 
reported in the literature documented a recanalization rate of 36% and a pregnancy rate of 
26%. Regarding cystic obstruction of the ED, TURED could be used in the seminal cysts 
communicating with the seminal tract. In the presence of non-communicating cysts 
(Müllerian or median), transrectal ultrasound-guided or percutaneous sclerotherapy are first 







Fig. 4. TURED 
Transrectal ultrasonically guided aspiration (TRUCA) of the seminal distal tract 
Transrectal ultrasonically guided cyst aspiration (TRUCA) is a minimally invasive 
technique, suitable to evacuate intraprostatic cysts that are making an extrinsic compression 
on the ED. The above are of Müllerian cysts that do not communicate with the ED and do 
not contain sperm. The aspiration of the cyst temporarily or permanently restores normal 
patency of the ED. This procedure is used as an alternative to endoscopic transurethral 
incision of the Müllerian cysts. 
Technical notes 
A transrectal probe of 6.5-7.5 MHz biplanar is used to perform this technique, with a 20-22 G 
Chiba needle guide connected to a 5 ml syringe for suction. The treatment is conducted with 
the patient placed on his left side, after oral antibiotic coverage The aspiration is performed 
with after the patient had abstained from sex from 4 to 5 days to determine the chemical-
physical characteristics of the aspirated fluid and the presence of sperm. Shortly after 
aspiration, the patient is requested to provide a semen sample for analysis. Immediately 
after, the clinician should recheck the cyst to assess its possible immediate filling (in this 
case, the cyst is communicating with the seminal tract, and therefore should not be 
inflexible). For sclerotherapy, an antibiotic (tetracycline) is instilled into the cyst at a rate of 
one-tenth of the previously aspirated volume. This procedure allows recovery of patency of 
the distal seminal tract in 75% of patients. 
Seminal tract washout therapy aims to restore the patency of the ejaculatory ducts 
Seminal Tract Washout (STW) therapy is indicated in azoospermic patients in whom an 
ultrasound of the distal seminal tract (controlled before and after ejaculation) documents 
obstruction of the orifices of the ED.1 This framework is characterized by an expansion of 
products that are associated with dilation of the seminal vesicles throughout their course,  
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Fig. 5. TRUCA 
possibly with seminal calcifications within them.  STW is not indicated in patients with a 
transrectal ultrasound examination that clearly shows a post-inflammatory obstruction of 
the ED. The STW runs with the same methods described for the STW designed to retrieve 
sperm for use in assisted reproduction. The unblocking of the orifice of the ED does not rule 
out the option of recovering and cryopreserving the sperm present in the seminal tract 
obstruction. 
4. Surgical or instrumental sperm collection for artificial insemination 
Testicular Sperm Extraction (TESE) 
TESE is the extraction of sperm from testicular parenchymal fragments obtained from single 
or multiple surgical biopsies. TESE was initially introduced by Silber et al. in 1995, as a 
method of sperm retrieval for ICSI in cases of azoospermia. 
TESE is one of several options for sperm retrieval in cases of OA, with directions more or 
less similar to other techniques. As a testicular removal, it has the advantage over 
epididymal sperm extraction (ESE) of not obstructing the patency of the epididymis tubule. 
This advantage can be especially important in cases of potentially reconstructible proximal 
obstructions (which remain the only curative option in reconstructive surgery), particularly 
those involving cases of distal ejaculation or anejaculation. Compared with epididymal 
microsurgical sperm aspiration (MESA), TESE permits the recovery of sperm, and is 
definitely easier because it does not require the use of a surgical microscope. TESE could be 
considered the ideal solution to retrieve sperm in those rare cases in which obstructive 
MESA fails, during the same surgical procedure. TESE is slightly more invasive and 
complex than the percutaneous techniques; however, in comparison TESE allows the 
recovery of a more appropriate number of sperm (almost always enough to freeze and use 
in subsequent cycles of ICSI). Several authors have proposed using TESE directly with 








   
(b) 
Fig. 6. (a) TESE, (b) TESA 
Epididymal Microsurgical Sperm Aspiration (MESA) 
MESA was the first sperm retrieval technique used for ART (Silber, 1987). While it was 
initially associated with IVF, since 1994 MESA has usually been associated with ICSI, even 
though the use of IVF may still be justified when sperm of good quality and quantity is 
recovered. MESA allows better recovery in terms of quantity and quality of sperm. Thanks 
to microsurgical techniques, it is possible to minimize blood contamination and choose the 
tubules with the best features for good sperm recovery.13 The chances of sperm retrieval 
with MESA are >95%, and it is almost always possible to freeze a sufficient number of 
sperm for any subsequent cycles of ICSI. Therefore, the male partner is usually subjected to 
a single intervention. The disadvantages of MESA arise because it is a complex technique 
that requires a manual microsurgical, as well as the availability of an operating microscope 
and proper instrumentation. The time and costs of MESA intervention are therefore higher 
than other techniques. MESA is now performed under local anesthesia with the patient's 
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immediate resignation. Normally it is sufficient to intervention only in cases of unilateral 
and insufficient sperm retrieval. 
Technical notes 
Traditional technique: General anesthesia, or local infiltration of the umbilical cord and the 
scrotal skin with any anesthesia care or sedation. A median scrotal incision is made with the 
opening of the tunica vaginalis and externalization of the testis. Under 20-30× magnification, 
a slot is removed from the head of the epididymis tunica albuginea and hemostasis is 
ensured with a bipolar forceps jeweler. The clinician then opens the tubule with 
microscissors and aspirates the liquid with a 22 or 23 G cannula mounted on an insulin 
syringe. Slight pressure on the testis and epididymis promotes the release of sperm. The 
extraction is continued with several syringes until leakage occurs, or until the biologist who 
monitors the sample finds it sufficient for freezing. Closure of the tubule with a 10/0 stitch 
is optional. In the variant proposed by Schlegel, instead of opening the tubule with 
microscissors, the tubule is pricked with a specially prepared, sharp glass micropipette 
connected to a suction system. This alternative saves time spent searching for the area with 
better sperm quality and minimizes blood contamination. 
Mini-MESA: In this variation of the technique, an incision is made approximately 1 cm from 
the window as a diagnostic testicular biopsy. Instead of exteriorizing the testicle, only the 
head of the epididymis is dislocated from the incision and secured with a stitch on the edge 
of the same. The technique then continues in the same way as the traditional technique, 
using a surgical microscope for subsequent phases of sperm aspiration from the epididymal 
tubules. Advantages of this alternative technique include the lack of externalization of the 
testis, reduction of pain experienced by the patient, and a minimized possibility of 
postoperative surgical adhesions. 
 
  
(a)        (b) 
Fig. 7. (a) MESA, (b) Mini MESA 
Epididymal Percutaneous Sperm Aspiration (PESA) 
Introduced by Craft in 1995, PESA represented the first "economic" alternative to MESA in 






economical, and minimally invasive. The main limitation of PESA is its lower efficacy 
compared with MESA sperm retrieval. In several studies, PESA seems to allow sperm 
recovery in approximately 60-70% of OA cases, compared with a 90-95% sperm recovery 
rate by MESA. The lower sperm recovery rate of PESA is presumably a consequence of the 
particular anatomic situation of the tubules of the head of the epididymis, which, when 
obstructed, are not uniformly dilated and do not contain the same amount or quality of 
sperm. If in the course of MESA is possible to drive on the intake and more dilated tubules 
with more chance of recovering motile sperm, PESA may just sting tubules without sperm 
or with sperm of poorer quality. Because PESA results in aspirated sperm of lower quantity 
and poorer quality, the possibility of freezing sperm for subsequent ICSI cycles is 
significantly lower with PESA than with MESA. By contrast, compared with TESA, PESA 
may allow better sperm retrieval, with less contamination from blood or other parenchymal 
cells. However, PESA involves an increased risk of scrotal hematoma than TESA, caused by 
the greater vascularity of the area of the head of the epididymis. PESA represents the 
technique of choice in cases of obstruction or congenital or acquired spermatocele in the 
epididymis. In this situation, PESA allows easy retrieval of a large amount of sperm with 
minimal invasiveness, and can be performed without any anesthesia. 
Technical Notes 
Regarding the need for anesthesia, the same considerations apply to PESA as to TESA. 
When aspirating, it is best to use a butterfly  needle (21 or 22 G) connected to a 20-ml or 
50-ml syringe. Aspiration should be applied to only the head of the epididymis, not to the 
body or tail. The clinician should immobilize the head of the epididymis by holding it 
between thumb and forefinger, and insert the needle into it. With the syringe, and always 
under slight suction, advance or retract the needle millimeter-wise until a small amount of 
clear liquid is observed in the connecting pipe. Continue suction until the flow stops. In 
most cases, this technique will result in a small quantity of well-aspirated sperm. The 
aspirated fluid is then diluted in culture medium and examined for sperm. If no sperm is 
recovered, the clinician should proceed to other aspirations, trying to puncture different 
parts of the head of the epididymis. It may help to exert pressure on the head of the 
epididymis for a few minutes, and to keep a bag of ice on the scrotum to minimize the risk 
of bleeding. 
 
Fig. 8. PESA 
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Epididymal Sperm Extraction (ESE) 
ESE is the surgical removal (no need for microsurgical techniques) of more or less 
substantial portions of the head of the epididymis for sperm extraction. ESE was described 
for the first time by Kim, although it had already been used sporadically by many clinicians. 
The extraction technique is identical to TESE. ESE has the advantage of being very fast, does 
not require the use of a surgical microscope, often provides excellent recoveries that are 
almost always sufficient to freeze sperm, and is associated with fertilization and pregnancy 
rates similar to those associated with other techniques. Its main disadvantages are that it is 
more invasive; the removal or parts of the epididymis is less repeatable (to be performed 
only in intractable situations of obstruction, such as CBAVD or congenital bilateral agenesis 
of the vasa deferentia); a higher risk of vascular damage to the testis; and increased blood 
contamination of the fragment to be treated. ESE is a viable option, and is therefore often 
used in the course of MESA, when it is not possible to retrieve sperm microaspirates from 
any of the epididymal sites. 
Technical Notes 
ESE can be performed under regional anesthesia or sedation. A medial scrotal incision is 
made, through which the testicle (or simply the head of the epididymis) is exteriorized. 
With scissors, the surgeon separates it from the testis to approximately 5 mm, dissecting 
some of the efferent vessels. The surgeon then uses scissors or a scalpel to cut a portion of 
the epididymis, and the entire head is immersed in a cell culture dish. Next, the biologist 
will perform the fragmentation of the piece first with scissors or scalpel and then slides with 
two sterile insulin needles. 
Surgical or instrumental collection of sperm for assisted fertilization: 
The vas deferens and distal seminal tract 
Microscopic Vasal Sperm Aspiration (MVSA) 
MVSA consists of the microsurgical aspiration of sperm from the lumen of the deferent. It is 
indicated in cases of distal deferential obstruction without any possibility of surgical 
reconstruction (e.g., iatrogenic damage from pelvic surgery or hernioplasty); cases of EDO; 
cases in which TURED or other techniques cannot be used to harvest sperm (e.g., DISTA); in 
cases of retrograde ejaculation with insufficient sperm retrieval from the post-orgasm urine; 
in cases of anejaculation due to different causes; or when vibrostimulation or 
electroejaculation fail. Finally, MVSA is indicated in selected cases of necrozoospermia or 
pronounced oligoastenozoospermia in the presence of structural or functional disorders of 
the emptying of the distal seminal tract that result in prolonged stagnation of the sperm. In 
these patients, sperm can be obtained from the deferent with good motility and vitality. The 
recovery of sperm cells that almost always exhibit very good motility makes it possible to 
opt for less invasive ART techniques (e.g., IVF, intrauterine insemination), as well as 
freezing. The main disadvantage of MVSA is that the procedure must be performed using 
microsurgical technique, which is essential for the closure of the rubble of the deferent 







MVSA is performed under local anesthesia by infiltration of the scrotal skin. A small 
incision is made in the scrotum to isolate the deferent and exteriorize it through the surgical 
access. The vas deferens is cut with a scalpel at the level of a straight portion. With a 23 or 24 
G cannula mounted on an insulin syringe or other suction system,3 it is then possible to 
proceed to the suction of seminal liquid from the lumen of the proximal stump of the 
deferent. The lumen must be closed with a microsurgical suture (Nylon 10/0), preferably in 
a double layer (2-3 and 5-6 inside-out stitches). 
Distal Seminal Tract Aspiration (DISTA) 
Designed as a diagnostic technique, DISTA was subsequently proposed as a treatment to 
support ART, particularly in cases of azoospermia secondary to an EDO. DISTA involves 
ultrasound-guided transperineal or transrectal fine needle aspiration of the liquid contained 
in the seminal vesicles, ED, or cysts of the seminal carrefour in patients with an obstruction 
of the seminal distal end, thereby achieving sperm retrieval for ART. 
The advantage of this technique is that it is minimally invasive compared with TURED; 
DISTA can be performed under local anesthesia and is easily repeatable. Furthermore, 
DISTA does not present any of the complications that may arise after TURED, such as the 
contamination of semen and the reflux of urine into the seminal tract due to the alteration of 
the antireflux mechanism of the ED. Compared with the techniques used to retrieve sperm 
from the more proximal seminal tract (deferens: MVSA; epididymis: MESA-PESA; the testis: 
TESE-TESA), DISTA has the advantages of avoiding the risk of secondary iatrogenic 
obstructions in these locations; of being quicker and simpler to perform; of being less costly 
compared with MVSA, MESA, and TESE; and of allowing sperm retrieval that is usually 
better than TESA, TESE, or PESA. DISTA almost always results in semen that can be frozen 
for future use in simple ART techniques. 
Its disadvantages include the persistent need of an ART technique and its dependence on 
the availability of an ultrasound machine, as well as even the possibility (albeit negligible) of 
ascending infections of the seminal tract. 
The primary indication for DISTA is cystic duct obstruction (where TURED is not indicated 
because of high risk); its secondary indication is prostatic cysts communicating with the 
seminal tract, or intraprostatic cysts in the ED with no obstructions. 
Technical Notes 
It is advisable to ejaculate the patient immediately before the procedure to increase the 
number of spermatozoa present in the distal seminal tract. The patient is placed in the 
lithotomic position or right lateral decubitus. After the administration of systemic antibiotics 
and enemas (in the case of transrectal puncture), the procedure requires a (preferably linear) 
transrectal ultrasound probe. The transperineal puncture is performed with local anesthesia. 
A 20-22 G Chiba type needle is guided by ultrasound to reach the dilated tract (seminal 
vesicle, ED, prostatic cyst communicating). The liquid content is then aspirated and sent to 
the laboratory for search and treatment of spermatozoa (swim-up, Percoll, mini-Percoll) to 
be used for ART. 
Transrectal ultrasonically guided sperm cyst aspiration (TRUSCA) can be used to retrieve 
sperm from Müllerian cysts or the urogenital sinus communicating with one or both ED. 
www.intechopen.com
 
Obstructive and Non-Obstructive Azoospermia 
 
17 
The semen from the aspirated cysts may be suitable for cryopreservation and for subsequent 
use in ICSI. It may be useful to repeat the procedure a few hours later and immediately after 
an ejaculation, to increase the likelihood of getting recent sperm  flow at the suction site. 
Seminal Tract Washout designed to recover sperm for assisted fertilization 
Seminal Tract Washout (STW) is an anterograde seminal tract cleaning that pushes 
spermatozoa from the tails of the epididymis into the bladder, recovering the latter 
spermatozoa from the bladder by catheterization. The spermatozoa are then cryopreserved 
or used fresh for ART. 
STW is a minimally invasive surgical procedure, applicable in azoospermic (or 
cryptozoospermic) patients with functional impairment of emptying of the distal seminal 
tract or a congenital or acquired incomplete anatomic obstruction of the ED. Even in patients 
with neurogenic anejaculation (an outcome of spinal cord injury of traumatic or iatrogenic 
origin, juvenile diabetes, or retroperitoneal lymph node dissection for unilateral testicular 
cancer) and in those with psychogenic anejaculation, sperm retrieval for IVF is satisfactory. 
Technical Notes 
STW is performed in the outpatient clinic. After the insertion of a Foley Ch 16-18 catheter 
into the bladder, T6 medium or Ham's F10 is used to wash the bladder and bring the pH to 
values appropriate to the maintenance of spermatozoa. Twenty milliliters of the same 
medium are left inside the bladder. Under local funicular anesthesia, the vas deferens is 
exteriorized with an Allis clamp and loaded between two vascular tapes to insert a 9.5 mm, 
25 G butterfly needle. 
A 2.5 ml syringe is needed to fill in anterograde direction 20 ml of T6 medium or Ham's F10 
for each side. The liquid is immediately recovered from the bladder through the previously 
inserted catheter and centrifuged (10 min, 600 g), and the pellet is treated with the mini-
Percoll technique. The obtained sperm can be used for artificial insemination in vivo or in 
vitro, or cryopreserved and subsequently used for ICSI. 
The full-term pregnancy rates of assisted reproductive technologyART with sperm retrieved 
using STW are high,4 and comparable to those obtained with testicular sperm from 
obstructive azoospermic subjects. 
STW is simple and inexpensive, and does not require microsurgical sutures or paramedical 
personnel. Compared with TESE and TEFNA, STW allows recovery of a much higher 
number of sperm, and obtains biological preparations suitable for assisted reproduction 
techniques in vivo, often without ICSI. 
STW is as invasive as a single sample pulp with TESE, and certainly less invasive than 
multiple TESE withdrawals. It does not require the opening of the tunica vaginalis, the 
externalization of the gonad, or the suture of the albuginea, and therefore does not carry a 
risk of bleeding. 
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